Early estimates indicate moderate growth in fertiliser sales volume in FY26 in India
On private sector capex, Mirae Asset's view is that it has been growing, but not in sectors like power, metal and mining.
Rural recovery looks imminent on the back of higher government spending and lower inflation
SCIL shows a strong growth potential owing to the healthy launches in the domestic market
The company’s superior execution in recent quarters makes it worthy of tracking. We see huge business opportunities emerging from the parent and group companies; investors can buy the stock on market dips
Agrochemical firm Best Agrolife Ltd on Monday reported a nearly three-fold jump in its net profit at Rs 104.76 crore in FY 2022. Its net profit stood at Rs 37.08 crore in the 2020-21 financial year, Best Agrolife Ltd (BAL) said in a statement.
IIL's export share can also improve to the 15-20 percent range of revenue, owing to higher penetration in new geographies, and a pick-up in product registration
Apart from the traditional agrochem business, PIND is getting enquiries for non-agrochem molecules that provide good growth opportunity
Sharda Cropchem reported impressive sales in the September quarter while commerce ministry data show continuing positive momentum in exports of agriculture sector tyres
Sharda Cropchem’s valuations are probably the lowest in the agrochem industry. The stock is trading at the lower end of its historical P/E multiples. Need more reasons to invest in the stock? Watch this video
With momentum building up once again in the primary market, Karunya Rao fills us in on all the things to know regarding the IPO of India Pesticides.
The factors that determine farm investments are still flashing green. Agriculture produce prices are firm and the government has sharply raised subsidy for fertilisers
Improving margins, strong balance sheet, healthy return on capital, capacity expansion and a gradual shift to a patented high-margin product mix and CRAMS make Bharat Rasayan attractive
While Rallis has tried to diversify into exports, seeds and CRAMs business, it lacks product differentiation
Stellar show by Kilpest in Q1, book gains and re enter on correction
Inexpensive valuation and a decent growth story make Insecticides India an attractive pick
Thanks to healthy financials, Insecticides India is better positioned than its peers
The list of expectations for the agri community is long. But then, the Budget will be a test of ability and willingness to spend
Post-correction, the stock is now trading at an FY19 estimated price-to-earnings of 14 times